Patents by Inventor Judith Kelleher

Judith Kelleher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thioether furan nitrone compounds
    Patent number: 5998469
    Abstract: Disclosed are novel thioether furan nitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals and as analytical reagents for detecting free radicals.
    Type: Grant
    Filed: January 14, 1999
    Date of Patent: December 7, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: Judith A. Kelleher, Kirk R. Maples, Yong-Kang Zhang
  • Furansulfonic acid derivatives and pharmaceutical compositions containing the same
    Patent number: 5994396
    Abstract: Disclosed are furansulfonic acid derivatives and pharmaceutical compositions containing such derivatives. The disclosed compositions are useful for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: November 30, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: Judith A. Kelleher, Kirk R. Maples, Yong-Kang Zhang
  • Furan nitrone compounds
    Patent number: 5942507
    Abstract: Disclosed are furan nitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compounds are useful as analytical reagents for detecting free radicals and as therapeutics for treating a wide variety of medical dysfunctions and diseases.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: August 24, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: Judith A. Kelleher, Kirk R. Maples, Lowell David Waterbury, Allan L. Wilcox, Hong Xu, Yong-Kang Zhang
  • Use of metabotropic receptor agonists in progressive neurodegenerative diseases
    Patent number: 5622981
    Abstract: A method of treating a mammal with a neurodegenerative disease which is caused at least in part by the neurotoxic effects of the .beta.-amyloid protein. This method constitutes administering a metabotropic receptor agonist to such a mammal. In particular, the agonist trans-ACPD or 1S,3R-ACPD can be administered intravenously to treat a mammal with Alzheimer's disease.
    Type: Grant
    Filed: April 7, 1995
    Date of Patent: April 22, 1997
    Assignee: Cortex Pharmaceuticals, Inc.
    Inventors: David D. Eveleth, Judith A. Kelleher, Carl W. Cotman
  • Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
    Patent number: 5567724
    Abstract: The present invention provides a method of inhibiting .beta.-amyloid toxicity in brain cells. The method includes administering to the cells an amount of an alkaline phosphatase inhibitor which is pharmacologically effective to reduce degeneration in the cells. Methods of treatment of peripheral neuropathy are also provided using acid or alkaline phosphatase inhibitors.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: October 22, 1996
    Assignee: Cortex Pharmaceuticals, Inc.
    Inventors: Judith A. Kelleher, David D. Eveleth